SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Naidu P.)
 

Sökning: WFRF:(Naidu P.) > Global phylogeny of...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00011076naa a2200949 4500
001oai:gup.ub.gu.se/310867
003SwePub
008240910s2021 | |||||||||||000 ||eng|
009oai:DiVA.org:oru-95586
024a https://gup.ub.gu.se/publication/3108672 URI
024a https://doi.org/10.1038/s41564-021-01000-z2 DOI
024a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-955862 URI
040 a (SwePub)gud (SwePub)oru
041 a eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Beale, M. A.u Parasites and Microbes Programme, Wellcome Sanger Institute, Hinxton, UK,Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK; Hospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust, London, UK,STI Unit Vall d'Hebron-Drassanes, Infectious Diseases Department, Hospital Vall d'Hebron, Barcelona, Spain4 aut
2451 0a Global phylogeny of Treponema pallidum lineages reveals recent expansion and spread of contemporary syphilis
264 c 2021-11-24
264 1b Springer Science and Business Media LLC,c 2021
500 a Funding agencies:National Health and Medical Research Council of Australia 1174555  United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) R01 AI123196  UK Research & Innovation (UKRI)Medical Research Council UK (MRC) MR/V027956/1  United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA R01 AI42143DH | NIHR | Programme Development Grants (NIHR Programme Development Grants) NIHR200125  European and Developing Countries Clinical Trials Partnership (EDCTP) RIA2018D-249
520 a Syphilis, which is caused by the sexually transmitted bacterium Treponema pallidum subsp. pallidum, has an estimated 6.3 million cases worldwide per annum. In the past ten years, the incidence of syphilis has increased by more than 150% in some high-income countries, but the evolution and epidemiology of the epidemic are poorly understood. To characterize the global population structure of T. pallidum, we assembled a geographically and temporally diverse collection of 726 genomes from 626 clinical and 100 laboratory samples collected in 23 countries. We applied phylogenetic analyses and clustering, and found that the global syphilis population comprises just two deeply branching lineages, Nichols and SS14. Both lineages are currently circulating in 12 of the 23 countries sampled. We subdivided T. p.pallidum into 17 distinct sublineages to provide further phylodynamic resolution. Importantly, two Nichols sublineages have expanded clonally across 9 countries contemporaneously with SS14. Moreover, pairwise genome analyses revealed examples of isolates collected within the last 20 years from 14 different countries that had genetically identical core genomes, which might indicate frequent exchange through international transmission. It is striking that most samples collected before 1983 are phylogenetically distinct from more recently isolated sublineages. Using Bayesian temporal analysis, we detected a population bottleneck occurring during the late 1990s, followed by rapid population expansion in the 2000s that was driven by the dominant T. pallidum sublineages circulating today. This expansion may be linked to changing epidemiology, immune evasion or fitness under antimicrobial selection pressure, since many of the contemporary syphilis lineages we have characterized are resistant to macrolides. Global syphilis prevalence has been increasing. Sequencing and analysis of a global collection of 726 Treponema pallidum samples reveal globally circulating lineages linked to a rapid expansion occurring since the end of the twentieth century.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Infektionsmedicin0 (SwePub)302092 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Infectious Medicine0 (SwePub)302092 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Dermatologi och venereologi0 (SwePub)302042 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Dermatology and Venereal Diseases0 (SwePub)302042 hsv//eng
653 a molecular clock
653 a r package
653 a selection
653 a yaws
653 a recombination
653 a visualization
653 a epidemiology
653 a algorithm
653 a sequence
653 a strains
653 a Microbiology
700a Marks, M.u The University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia; Pathology Queensland Central Laboratory, Brisbane, Queensland, Australia4 aut
700a Cole, M. J.u HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK4 aut
700a Lee, M. K.u British Columbia Centre for Disease Control, Public Health Laboratory, Vancouver, British Columbia, Canada; Clinical Microbiology Department, Queen Elizabeth Hospital, Birmingham, UK4 aut
700a Pitt, R.u HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK4 aut
700a Ruis, C.u Molecular Immunity Unit, MRC-Laboratory of Molecular Biology, Department of Medicine, University of Cambridge, Cambridge, UK; Department of Veterinary Medicine, University of Cambridge, Cambridge, UK,Department of Clinical Sciences, Institute of Tropical Medicine, Antwerpen, Belgium4 aut
700a Balla, E.u Bacterial STIs Reference Laboratory, Department of Bacteriology, National Public Health Centre, Budapest, Hungary4 aut
700a Crucitti, T.u Department of Clinical Sciences, Institute of Tropical Medicine, Antwerpen, Belgium4 aut
700a Ewens, M.u Brotherton Wing, Leeds General Infirmary, Leeds, UK4 aut
700a Fernandez-Naval, C.u Microbiology Department, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain4 aut
700a Grankvist, A.u National Reference Laboratory for STIs, Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Sweden4 aut
700a Guiver, M.u Laboratory Network, Manchester, UK Health Security Agency, Manchester Royal Infirmary, Manchester, UK,British Columbia Centre for Disease Control, Public Health Laboratory, Vancouver, British Columbia, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada4 aut
700a Kenyon, C. R.u Colorado School of Public Health, University of Colorado, Denver, CO, USA4 aut
700a Khairullin, R.u Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia4 aut
700a Kularatne, R.u Centre for HIV and STI, National Institute for Communicable Diseases, Johannesburg, South Africa4 aut
700a Arando, M.4 aut
700a Molini, B. J.u Department of Medicine, University of Washington, Seattle, WA, USA4 aut
700a Obukhov, A.u Tuvan Republican Skin and Venereal Diseases Dispensary, Ministry of Health of Tuva Republic, Kyzyl, Russia4 aut
700a Page, E. E.u Virology Department, Old Medical School, Leeds Teaching Hospitals Trust, Leeds, UK4 aut
700a Petrovay, F.u Bacterial STIs Reference Laboratory, Department of Bacteriology, National Public Health Centre, Budapest, Hungary4 aut
700a Rietmeijer, C.4 aut
700a Rowley, D.u Midlands Regional Hospital Portlaoise, Laois, Ireland4 aut
700a Shokoples, S.u Alberta Precision Laboratories, Edmonton, Alberta, Canada4 aut
700a Smit, E.u Clinical Microbiology Department, Queen Elizabeth Hospital, Birmingham, UK; Institute of Environmental Science and Research, Wellington, New Zealand4 aut
700a Sweeney, E. L.u The University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia4 aut
700a Taiaroa, G.u Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia4 aut
700a Vera, J. H.u Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, UK4 aut
700a Wennerås, Christine,d 1963u Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för infektionssjukdomar,Institute of Biomedicine, Department of Infectious Medicine,National Reference Laboratory for STIs, Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden4 aut0 (Swepub:gu)xwennc
700a Whiley, D. M.4 aut
700a Williamson, D. A.u Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia4 aut
700a Hughes, G.u Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK4 aut
700a Naidu, P.u Alberta Precision Laboratories, Edmonton, Alberta, Canada; Department of Laboratory Medicine and Pathology, Faculty of Medicine, University of Alberta, Edmonton, Alberta, Canada4 aut
700a Unemo, Magnus,d 1970-u Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,WHO Collaborating Centre for Gonorrhoea and other Sexually Transmitted Infections, National Reference Laboratory for STIs, Faculty of Medicine and Health4 aut0 (Swepub:oru)muo
700a Krajden, M.4 aut
700a Lukehart, S. A.u Departments of Medicine/Infectious Diseases and Global Health, University of Washington, Seattle, WA, USA4 aut
700a Morshed, M. G.4 aut
700a Fifer, H.u Blood Safety, Hepatitis, STI and HIV Division, UK Health Security Agency, London, UK4 aut
700a Thomson, N. R.u Parasites and Microbes Programme, Wellcome Sanger Institute, Hinxton; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK4 aut
710a Parasites and Microbes Programme, Wellcome Sanger Institute, Hinxton, UKb Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK; Hospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust, London, UK4 org
773t Nature Microbiologyd : Springer Science and Business Media LLCg 6:12q 6:12x 2058-5276
856u https://www.nature.com/articles/s41564-021-01000-z.pdf
856u https://doi.org/10.1038/s41564-021-01000-zy Fulltext
8564 8u https://gup.ub.gu.se/publication/310867
8564 8u https://doi.org/10.1038/s41564-021-01000-z
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-95586

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy